These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30214812)

  • 1. Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study.
    Litton E; Baker S; Erber W; Farmer S; Ferrier J; French C; Gummer J; Hawkins D; Higgins A; Hofmann A; De Keulenaer B; McMorrow J; Olynyk JK; Richards T; Towler S; Trengove R; Webb S; ;
    J Intensive Care; 2018; 6():60. PubMed ID: 30214812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia.
    Litton E; Baker S; Erber W; French C; Ferrier J; Hawkins D; Higgins AM; Hofmann A; Keulenaer BL; Farmer S; McMorrow J; Olynyk J; Richards T; Towler S; Webb S;
    Crit Care Resusc; 2014 Dec; 16(4):285-90. PubMed ID: 25437223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness.
    ; Litton E; Baker S; Erber WN; Farmer S; Ferrier J; French C; Gummer J; Hawkins D; Higgins A; Hofmann A; De Keulenaer B; McMorrow J; Olynyk JK; Richards T; Towler S; Trengove R; Webb S;
    Intensive Care Med; 2016 Nov; 42(11):1715-1722. PubMed ID: 27686346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron-restricted erythropoiesis and risk of red blood cell transfusion in the intensive care unit: a prospective observational study.
    Litton E; Xiao J; Allen CT; Ho KM
    Anaesth Intensive Care; 2015 Sep; 43(5):612-6. PubMed ID: 26310412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased total iron binding capacity upon intensive care unit admission predicts red blood cell transfusion in critically ill patients.
    Imaeda T; Nakada TA; Abe R; Oda S
    PLoS One; 2019; 14(1):e0210067. PubMed ID: 30673726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron supplementation to treat anaemia in adult critical care patients: a systematic review and meta-analysis.
    Shah A; Roy NB; McKechnie S; Doree C; Fisher SA; Stanworth SJ
    Crit Care; 2016 Sep; 20(1):306. PubMed ID: 27681259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial.
    Lasocki S; Asfar P; Jaber S; Ferrandiere M; Kerforne T; Asehnoune K; Montravers P; Seguin P; Peoc'h K; Gergaud S; Nagot N; Lefebvre T; Lehmann S;
    Crit Care; 2021 Feb; 25(1):62. PubMed ID: 33588893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative intravenous iron for anaemia in elective major open abdominal surgery: the PREVENTT RCT.
    Richards T; Baikady RR; Clevenger B; Butcher A; Abeysiri S; Chau M; Swinson R; Collier T; Dodd M; Dyck LV; Macdougall I; Murphy G; Browne J; Bradbury A; Klein A
    Health Technol Assess; 2021 Feb; 25(11):1-58. PubMed ID: 33632377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of iron therapy on reducing red blood cell transfusion requirements and treating anaemia in critically ill adults: A systematic review with meta-analysis and trial sequential analysis.
    Shah A; Fisher SA; Wong H; Roy NB; McKechnie S; Doree C; Litton E; Stanworth SJ
    J Crit Care; 2019 Feb; 49():162-171. PubMed ID: 30448516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of red blood cell transfusion on iron metabolism in critically ill patients.
    Boshuizen M; van Hezel ME; van Manen L; Straat M; Somsen YBO; Spoelstra-de Man AME; Blumberg N; van Bruggen R; Juffermans NP
    Transfusion; 2019 Apr; 59(4):1196-1201. PubMed ID: 30597563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
    Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Shapiro MJ; Corwin MJ; Colton T;
    JAMA; 2002 Dec; 288(22):2827-35. PubMed ID: 12472324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial.
    Spahn DR; Schoenrath F; Spahn GH; Seifert B; Stein P; Theusinger OM; Kaserer A; Hegemann I; Hofmann A; Maisano F; Falk V
    Lancet; 2019 Jun; 393(10187):2201-2212. PubMed ID: 31036337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study protocol and pilot results of an observational cohort study evaluating effect of red blood cell transfusion on oxygenation and mitochondrial oxygen tension in critically ill patients with anaemia: the INsufficient Oxygenation in the Intensive Care Unit (INOX ICU-2) study.
    Baysan M; Arbous MS; Mik EG; Juffermans NP; van der Bom JG
    BMJ Open; 2020 May; 10(5):e036351. PubMed ID: 32423938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of iron deficiency diagnosis using hepcidin mass spectrometry dosage methods on hospital stay and costs after a prolonged ICU stay: Study protocol for a multicentre, randomised, single-blinded medico-economic trial.
    Lasocki S; Puy H; Mercier G; Lehmann S;
    Anaesth Crit Care Pain Med; 2017 Dec; 36(6):391-396. PubMed ID: 28919067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
    Estcourt LJ; Malouf R; Trivella M; Fergusson DA; Hopewell S; Murphy MF
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011305. PubMed ID: 28128441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*.
    Pieracci FM; Stovall RT; Jaouen B; Rodil M; Cappa A; Burlew CC; Holena DN; Maier R; Berry S; Jurkovich J; Moore EE
    Crit Care Med; 2014 Sep; 42(9):2048-57. PubMed ID: 24797376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of preoperative intravenous iron therapy to correct anemia before major surgery: study protocol for systematic review and meta-analysis.
    Elhenawy AM; Meyer SR; Bagshaw SM; MacArthur RG; Carroll LJ
    Syst Rev; 2015 Mar; 4():29. PubMed ID: 25874460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron deficiency diagnosed using hepcidin on critical care discharge is an independent risk factor for death and poor quality of life at one year: an observational prospective study on 1161 patients.
    Lasocki S; Lefebvre T; Mayeur C; Puy H; Mebazaa A; Gayat E;
    Crit Care; 2018 Nov; 22(1):314. PubMed ID: 30463596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.
    Holst LB
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study.
    Jackson Chornenki NL; James TE; Barty R; Liu Y; Rochwerg B; Heddle NM; Siegal DM
    Transfusion; 2020 Feb; 60(2):256-261. PubMed ID: 31883275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.